Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea.
Department of Internal Medicine and Environmental Health Center, Kangwon National University Hospital, Chuncheon, Republic of Korea.
BMC Pulm Med. 2023 May 3;23(1):155. doi: 10.1186/s12890-023-02451-2.
Although preserved ratio impaired spirometry (PRISm) has been determined to have poor prognosis, it is a heterogeneous state, and studies regarding its prognosis in Asians are limited. This study investigated the long-term all-cause and cardiovascular mortality of patients with PRISm compared with those of patients with chronic obstructive pulmonary disease (COPD) and normal individuals in the Korean middle-aged general population.
Participants were recruited between 2001 and 2002 from a community-based prospective cohort in South Korea. Mortality data were collected over a 16.5-year mean follow-up period. The all-cause and cardiovascular mortality risks of PRISm were compared between patients with COPD and healthy controls.
The PRISm group had a mean age of 53.4 years and mean body mass index of 24.9 kg/m; furthermore, 55.2% of the PRISm patients had never smoked, and the prevalence of comorbidities was not higher than that in the other groups. Compared with normal individuals, PRISm patients did not show increased all-cause mortality, whereas COPD patients showed increased all-cause mortality (PRISm: adjusted hazard ratio [aHR], 1.19; 95% confidence interval [CI], 0.85-1.65; COPD: aHR, 1.34, 95% CI, 1.07-1.69). Furthermore, the PRISm patients did not show increased cardiovascular mortality compared with normal individuals (PRISm: aHR, 1.65; 95% CI, 0.92-2.95; COPD: aHR, 1.83; 95% CI, 1.09-3.07).
In our population-based cohort, all-cause and cardiovascular mortality risk did not increase in individuals with PRISm compared with normal individuals. Further studies are needed to distinguish a lower-risk subgroup of PRISm with certain characteristics, such as middle-aged, light-smoking Asians without additional cardiovascular risk.
虽然保留比肺活量(PRISm)受损已被确定为预后不良,但它是一种异质状态,关于其在亚洲人群中的预后研究有限。本研究旨在调查与慢性阻塞性肺疾病(COPD)患者和韩国中年普通人群中的正常个体相比,PRISm 患者的长期全因和心血管死亡率。
参与者于 2001 年至 2002 年期间在韩国的一个基于社区的前瞻性队列中招募。在 16.5 年的平均随访期间收集死亡率数据。比较 COPD 患者和健康对照组 PRISm 患者的全因和心血管死亡风险。
PRISm 组的平均年龄为 53.4 岁,平均体重指数为 24.9 kg/m;此外,55.2%的 PRISm 患者从未吸烟,且合并症的患病率并不高于其他组。与正常个体相比,PRISm 患者的全因死亡率没有增加,而 COPD 患者的全因死亡率增加(PRISm:调整后的危险比 [aHR],1.19;95%置信区间 [CI],0.85-1.65;COPD:aHR,1.34,95% CI,1.07-1.69)。此外,与正常个体相比,PRISm 患者的心血管死亡率没有增加(PRISm:aHR,1.65;95% CI,0.92-2.95;COPD:aHR,1.83;95% CI,1.09-3.07)。
在我们的基于人群的队列中,与正常个体相比,PRISm 个体的全因和心血管死亡风险没有增加。需要进一步的研究来区分具有某些特征的 PRISm 的低风险亚组,例如没有其他心血管风险的中年、轻度吸烟的亚洲人。